Cardiac outcomes reported in the MINT trial. In the MINT trial, the point estimates strongly favored the liberal transfusion strategy for the primary and secondary outcomes: death, cardiac death, recurrent MI, and the composite of death, MI, ischemia-driven unscheduled coronary revascularization, or readmission to the hospital for an ischemic cardiac event. Modified from Carson et al with permission.¹⁴